Corneal Defect

9 registered clinical trials studyying Corneal Defect.

Status	Trial	Sponsor	Phase
Completed	Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease NCT05204329	University of Illinois at Chicago	EARLY_Phase 1
Completed	Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery NCT05626478	Nicole Fram M.D.	Phase 4
Unknown	Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort NCT05458661	Carl Zeiss Meditec AG	N/A
Completed	The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study NCT03967548	Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.	Phase 1
Completed	A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery NCT04975971	Nicole Fram M.D.	—
Completed	Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells NCT04626583	University of Illinois at Chicago	Phase 1
Unknown	Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects NCT04228926	Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.	Phase 2
Completed	Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery NCT04521140	Nicole Fram M.D.	Phase 4
Completed	Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers NCT03662971	Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.	Phase 1